One of the themes of the current tech boom has been big data, which promises to change everything from business to government, to medicine. 23andMe is a startup that offers genetic tests for $99. Earlier this week 23andMe struck a deal with the drug company Pfizer, which is paying an undisclosed sum to get the genetic information of 5,000 people in 23andMe's database.
upper waypoint
lower waypoint
next waypoint
Stay on top of what’s happening in the Bay Area
Subscribe to News Daily for essential Bay Area news stories, sent to your inbox every weekday.
To learn more about how we use your information, please read our privacy policy.